Disc Medicine (IRON) Research & Development (2020 - 2026)

Disc Medicine (IRON) has 7 years of Research & Development data on file, last reported at $45.9 million in Q1 2026.

• Quarterly Research & Development rose 65.34% year-over-year to $45.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $188.8 million (up 87.41% YoY) and the FY2025 annual result came in at $170.6 million, up 76.52% from the prior year.
• Research & Development declined to $45.9 million in Q1 2026 per IRON's latest filing, from $46.2 million in the prior quarter.
• Across five years, Research & Development topped out at $50.3 million in Q3 2025 and bottomed at $7.7 million in Q2 2022.
• The 5-year median for Research & Development is $23.5 million (2024), against an average of $24.5 million.
• Peak annual rise in Research & Development reached 191.78% in 2022, while the deepest fall reached 41.39% in 2022.
• Tracing IRON's Research & Development over 5 years: stood at $10.0 million in 2022, then soared by 125.29% to $22.6 million in 2023, then rose by 9.89% to $24.8 million in 2024, then surged by 86.41% to $46.2 million in 2025, then decreased by 0.69% to $45.9 million in 2026.
• Per Business Quant, the three latest IRON Research & Development figures stand at $45.9 million (Q1 2026), $46.2 million (Q4 2025), and $50.3 million (Q3 2025).

Peer Comparison